Urological Research

, Volume 21, Issue 1, pp 27–32 | Cite as

Characterization of insulin-like growth factor I binding sites in human bladder cancer cell lines

  • Masatsugu Iwamura
  • Motomi Ishibe
  • Patrick M. Sluss
  • Abraham T. K. Cockett
Original Articles

Summary

The role of insulin-like growth factor I (IGF-I) in the growth and development of bladder cancer cells was investigated using cultured human cell lines representing differentiated (RT-4, 5637) or undifferentiated (T-24, J-82, TCC-SUP) transitional cell carcinoma (TCC). In the presence of 2% serum, IGF-I significantly stimulated the growth of all cell lines. The proliferation of T-24, 5637, and RT-4 cells was more sensitive to IGF-I than that of J-82 and TCC-SUP cells. [125I]IGF-I binding to 5637 and J-82 cells was significantly higher than that to T-24 and TCC-SUP cells (P<0.001). RT-4 cells possessed the lowest binding capacity among the cell lines tested. Scatchard analysis of [125I]IGF-I binding to four of the five cell lines indicated a single binding site for IGF-I, with apparent dissociation constants (Kd) of 1.27, 1.18, 1.34, and 1.39 nmol/l for TCC-SUP, J-82, 5637, and T-24, respectively. Therefore, the difference observed in [125I]IGF-I binding among the bladder cancer cell lines was attributed to the difference of IGF-I binding sites and not to a change in receptor binding affinity. Cross-linking studies supported the suggestion that [125I]IGF-I was bound to a receptor on these cells. The results indicate that cultured human bladder cancer cells contain functional IGF-I receptors. A differentiated cell line, RT-4, possesses significantly fewer IGF-I receptors than other cell lines. This suggests that the overexpression of IGF-I receptor may reflect the malignant potential of bladder cancer cells.

Key words

Human bladder cancer IGF-I receptor 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Berger MS, Greenfield C, Gullick WJ, Haley J, Downward J, Neal DE et al (1987) Evaluation of epidermal growth factor receptors in bladder tumors. Br J Cancer 56:533–537Google Scholar
  2. 2.
    Bleday R, Tzanakakis GN, Schwalke MA, Wanebo HJ, Vezeridis MP (1990) Epidermal growth factor stimulation and metastatic rate in human pancreatic carcinoma cell lines. J Surg Res 49:276–279Google Scholar
  3. 3.
    Eloch A (1984) Induced cell differentiation in cancer therapy. Cancer Treat Rep 68:199–205Google Scholar
  4. 4.
    Bunenik J, Baresova M, Viklicky V, Jakoubkova J, Sainerova H, Donner J (1973) Established cell line of urinary bladder carcinoma (T24) containing tumor-specific antigen. Int J Cancer 11:765–773Google Scholar
  5. 5.
    Czech MP (1989) Signal transmission by the insulin-like growth factors. Cell 59:235–238Google Scholar
  6. 6.
    Daughaday WH (1990) Editorial: the possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology 127:1–4Google Scholar
  7. 7.
    D'Ercole AJ, Stiles AD, Underwood LE (1984) Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanism of action. Proc Natl Acad Sci USA 81:935–939Google Scholar
  8. 8.
    Dulak NC, Temin HM (1973) A partially purified polypeptide fraction from rat liver cell conditioned medium with multiplication-stimulating activity for embryo fibroblasts. J Cell Physiol 81:153–160Google Scholar
  9. 9.
    Fiorelli G, De Bellis A, Longo A, Giannini S, Natali A, Constantini A et al. (1991) Insulin-like growth factor-I receptors in human hyperplastic prostate tissue: characterization, tissue localization, and their modulation by chronic treatment with a gonadotropin-releasing hormone analog. J Clin Endocrinol Metab 72:740–746Google Scholar
  10. 10.
    Froesch ER, Schmid C, Schwander J, Zapf J (1985) Action of insulin-like growth factors. Annu Rev Physiol 47:443–467Google Scholar
  11. 11.
    Goustin AS, Leof EB, Shipley GD, Moses HL (1986) Growth factors and cancer. Cancer Res 46:1015–1029Google Scholar
  12. 12.
    Heldin C-H, Westermark B (1984) Growth factors: mechanism of action and relation to oncogeneses. Cell 37:9–20Google Scholar
  13. 13.
    Kurose H, Yamaoka K, Okada S, Nakajima S, Seino Y (1990) 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3]increases insulin-like growth factor I (IGF-I) receptors in clonal osteoblastic cells: study on interaction of IGF-I and 1,25-(OH)2D3. Endocrinology 126:2088–2094Google Scholar
  14. 14.
    Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277:680–685Google Scholar
  15. 15.
    Laiho M, Keski-Oja J (1989) Growth factors in the regulation of pericellular proteolysis: a review. Cancer Res 49:2533–2553Google Scholar
  16. 16.
    Lee K, Smith P, Weiss GH, Cockett ATK (1990) Clonal growth of bladder cancer cells in a double layer soft agar assay: needless addition of multiple culture supplements. Urol Res 18:197–200Google Scholar
  17. 17.
    Liotta LA (1986) Tumor invasion and metastasis: role of the extracellular matrix. Rhoads memorial award lecture. Cancer Res 46:1–7Google Scholar
  18. 18.
    Lund PK, Moats-Staats BM, Hynes MA, Simmons JG, Jansen M, D'Ercole AJ, Van Wyk JJ (1986) Somatomedin C/insulin-like growth factor I and insulin-like growth factor II mRNAs in rat fetal and adult tissues. J Biol Chem 261:14539–14544Google Scholar
  19. 19.
    Messing EM, Reznikoff CA (1987) Normal and malignant human epithelium: in vitro effects of epidermal growth factor. Cancer Res 47:2230–2235Google Scholar
  20. 20.
    Monaghan P, Ormerod MG, O'Hare MJ (1990) Epidermal growth factor receptors and EGF-responsiveness of the human breast-carcinoma cell line PMC42. Int J Cancer 46:935–943Google Scholar
  21. 21.
    Murphy AJ, Bell GI, Friesen HG (1987) Tissue distribution of insulin-like growth factor I and II messenger ribonucleic acid in the adult rat. Endocrinology 12:1279–1282Google Scholar
  22. 22.
    Nayak SK, O'Toole C, Price ZH (1977) A cell line from an anaplastic transitional cell carcinoma of human urinary bladder. Br J Cancer 35:142–151Google Scholar
  23. 23.
    Neal DE, Marsh C, Bennet MK, Abel PD, Hall RR, Sainsbury JRC et al (1985) Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumors. Lancet I:366–368Google Scholar
  24. 24.
    Neal DE, Sharples L, Smith K, Fennelly J, Hall RR, Harris AL (1990) The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer 65:1619–1625Google Scholar
  25. 25.
    O'Toole C, Price ZH, Ohnuki Y, Unsgaard B (1978) Ultrastructure, karyology and immunology of a cell line originated from a human transitional-cell carcinoma. Br J Cancer 38:64–76Google Scholar
  26. 26.
    Pilch PF, Czech MP (1980) The subunit structure of the high-affinity insulin receptor. J Biol Chem 255:1722–1731Google Scholar
  27. 27.
    Pollak MN, Polychronakos C, Yousefi S, Richard M (1988) Characterization of insulin-like growth factor I (IGF-I) receptors of human breast cancer cells. Biochem Biophys Res Commun 154:326–331Google Scholar
  28. 28.
    Reiss K, Ferber A, Travali S, Procu P, Phillips PD, Baserga R (1991) The protooncogene c-myb increases the expression of insulin-like growth factor I and insulin-like growth factor I receptor messenger RNAs by a transcriptional mechanism. Cancer Res 51:5997–6000Google Scholar
  29. 29.
    Rigby CC, Franks LM (1970) A human tissue culture cell line from a transitional cell tumor of the urinary bladder: growth, chromosome pattern and ultrastructure. Br J Cancer 24:746–754Google Scholar
  30. 30.
    Ritvos O, Rutanen E, Pekonen F, Jalkanen J, Suikkari A, Ranta T (1988) Characterization of functional type I insulin-like growth factor receptors from human choriocarcinoma cells. Endocrinology 122:395–401Google Scholar
  31. 31.
    Scatchard G 81949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672Google Scholar
  32. 32.
    Sporn MB, Roberts AB (1985) Autocrine growth factors and cancer. Nature 313:745–747Google Scholar
  33. 33.
    Stracke ML, Engel JD, Wilson LW, Rochler MM, Liotta LA, Schiffmann E (1989) The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. J Biol chem 264:21544–21549Google Scholar
  34. 34.
    Talavera F, Reynolds RK, Roberts JA, Menon KM (1990) Insulin-like growth factor I receptors in normal and neoplastic human endometrium. Cancer Res 50:3019–3024Google Scholar
  35. 35.
    Weiss RE, Liu BC-S, Ahlering T, Dubean L, Droller MJ (1990) Mechanisms of human bladder tumor invasion: role of protease cathepsin. B. J Urol 144:798–804Google Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • Masatsugu Iwamura
    • 1
  • Motomi Ishibe
    • 1
  • Patrick M. Sluss
    • 1
  • Abraham T. K. Cockett
    • 1
  1. 1.Department of Urology and Department of OrthopedicsUniversity of Rochester School of MedicineRochesterUSA

Personalised recommendations